Internal Medicine

As symptoms reportedly reach the majority of the US physician population, it's time to discuss individual strategy to reduce the risk and effect of burnout.

Patients express worry related to using opioids and that they are not always on the same page as their provider.

How can primary care and family physicians help put concerned patients at ease?

The Novalung System is the first ECMO device approved for use for more than 6 hours.

Clinical trial data for the lipid-lowering non-statin agent indicates it can lower LDL-C by as much as 18% when combined with maximally tolerated statins.

A secondary analysis of patients with prior stroke, TIA, or thromboembolism from AUGUSTUS is revealing more about the use of apixaban in patients with AFib.

The adoption of remote treatment monitoring apps improves the timely identification of complications and intervention by care teams.

New data indicates a combination of 3 natural extracts added to standard therapy could provide benefits in patients with uncontrolled hypertension.

New drug more often linked to a full ON response from Parkinson disease patients at 30 minutes when compared to a placebo.

The approval came following 2 Complete Response Letters from the FDA.

The new low nicotine products contain 95% less nicotine than the top 100 cigarette brands in the US, according to 22nd Century Group.

Younger patients display increased susceptibility to H1N1 relative to H3N2, according to study findings.

Despite a lack of previous research, investigators conclude in a new study that sex has a moderate effect on symptom presentation following a traumatic brain injury.

Macrolide use during the first trimester was linked to an increase in major malformations—specifically cardiovascular malformations—in children.

A fourth-year medical student keeps a log of the sessions he attends and his perspective on information from the SCCM's 49th Annual Critical Care Congress.

A new analysis is revealing more about how using a patient portal can aid in medication adherence and HbA1c management among diabetics.

The Prometra II offers a pressure-driven, valve-gated delivery mechanism that allows for novel programming modes of intermittent flow followed by periods of no flow—a feature unique to this device.

New data on the use of polygenic risk scores for predicting certain forms of cardiovascular disease raise questions about the validity of genetic scores in real-world settings.

Current patients can easily exceed the current CDC guidelines for opioids, recent study findings suggest.

Azathioprine is linked to a slightly higher eGFR for patients with inflammatory bowel disease.

A new guidance breaks ground as the first of its kind to assist physicians in screening for, and treating, vaping-associated respiratory disease syndrome.

A new study from the Columbia University Irving Medical Center found another diuretic appeared to have less serious side effects than the guideline-recommended chlorthalidone.

Patients are satisfied with an online cost-estimator tool, according to findings of a recent study.

A study from Rutgers University is shedding more light on the additional cardiovascular risk among preeclamptic women.

Investigators conduct the first ever treat-to-target study looking at ustekinumab maintenance therapy for Crohn’s disease patients.